Related Experiment Video
Updated: Jul 14, 2026
07:01
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Antiepileptic drugs and mood stability
Benedikt Amann1, Heinz Grunze, Eduard Vieta
1Hospital Benito Menni, Dr. Antoni Pujadas 38, 08830 Sant Boi, Barcelona, Spain. benedikt.amann@med.uni-muenchen.de
Clinical EEG and Neuroscience
|May 23, 2007
Summary
This review examines antiepileptic drugs like carbamazepine, valproate, and lamotrigine as mood stabilizers for bipolar disorder. Their efficacy varies, suggesting combined treatments may be optimal for managing mood states.
Area of Science:
- Neuroscience and Pharmacology
- Psychiatry and Mental Health
Background:
- Mood stabilizers are crucial for managing bipolar disorder, but definitions and efficacies vary.
- Antiepileptic drugs (AEDs) like carbamazepine, valproate, and lamotrigine are frequently used.
- Understanding their specific roles in mood stabilization is essential for effective treatment.
Purpose of the Study:
- To critically evaluate the definitions and applications of mood stabilizers.
- To compare the efficacy of carbamazepine, valproate, and lamotrigine in stabilizing mood in bipolar patients.
- To explore the differential efficacy of AEDs in preventing depressive versus hypo-/manic episodes.
Main Methods:
- A comprehensive Medline search was conducted up to 2006.
- Focused on controlled acute and maintenance studies of carbamazepine, valproate, and lamotrigine.
- Analysis of drug mechanisms of action and clinical efficacy in epilepsy and bipolar disorder.
Main Results:
- Carbamazepine, valproate, and lamotrigine exhibit heterogeneous mechanisms and efficacies.
- Lamotrigine is approved for preventing bipolar depressive episodes, prompting comparisons with other AEDs.
- These AEDs only partially meet the criteria for mood stabilizers.
Conclusions:
- The efficacy of carbamazepine, valproate, and lamotrigine as mood stabilizers is varied.
- Differential efficacy exists for preventing specific mood states in bipolar disorder.
- Future research should investigate combined treatment strategies for optimal mood stabilization.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...